The Global NSCLC market is expected to reach USD 38.8 Billion by 2030, at a CAGR of 10.4% during the forecast period 2022 to 2030.The most typical form of lung cancer is non-small cell lung carcinoma (NSCLC), also referred to as non-small cell lung cancer. The description "non-small cell" describes how cancer cells seem under a microscope.